Testicular Uptake and Radiation Dose in Patients Receiving Zevalin™ and Pretarget™ CC49Fusion Protein-Reference-Cited by-同舟云学术

Testicular Uptake and Radiation Dose in Patients Receiving Zevalin™ and Pretarget™ CC49Fusion Protein

Published:2005-02 Issue:1 Volume:20 Page:110-118
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Shen Sui¹,Meredith Ruby¹,Duan Jun¹,Forero Andres²,Breitz Hazel³,Khazaeli M.B.¹,Brezovich Ivan¹,LoBuglio Albert²

Affiliation:

1. Department of Radiation Oncology, University of Alabama, Birmingham, AL.

2. Department of Medicine, Comprehensive Cancer Center, University of Alabama, Birmingham, AL.

3. NeoRx Corporation, Seattle, WA.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2005.20.110

Reference20 articles.

1. Treatment of B cell malignancies with131I LYM-1 monoclonal antibodies

2. Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

3. Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody

4. Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma

5. Effect of Graded Doses of Ionizing Radiation on the Human Testis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testis dosimetry in individual patients by combining a small-scale dosimetry model and pharmacokinetic modeling-application of111In-Ibritumomab Tiuxetan (Zevalin®);Physics in Medicine and Biology;2014-11-26

2. A Small-Scale Anatomic Model for Testicular Radiation Dosimetry for Radionuclides Localized in the Human Testes;Journal of Nuclear Medicine;2011-11-11

3. MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- and 90Y-Ibritumomab Tiuxetan;Journal of Nuclear Medicine;2009-03-16